MedPath

Eastern Hepatobiliary Surgery Hospital

🇨🇳China
Ownership
-
Established
1956-01-01
Employees
-
Market Cap
-
Website
http://www.ehbh.cn/

Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma

Phase 1
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2015-10-26
Last Posted Date
2016-04-01
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
300
Registration Number
NCT02586285
Locations
🇨🇳

Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System

Not Applicable
Conditions
Hepatocellular Carcinoma
Interventions
Procedure: Hepatectomy
Procedure: TACE
First Posted Date
2015-08-18
Last Posted Date
2016-03-31
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
320
Registration Number
NCT02525952
Locations
🇨🇳

Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma

Not Applicable
Conditions
Hepatocellular Carcinoma
Interventions
Procedure: Narrow resection margin <1cm
Procedure: Wide resection margin >1cm
First Posted Date
2015-08-18
Last Posted Date
2016-03-31
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
194
Registration Number
NCT02525965
Locations
🇨🇳

Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Conventional or Unconventional Lymph Node Dissection During Resection of Intrahepatic Cholangiocarcinoma

Not Applicable
Conditions
Intrahepatic Cholangiocarcinoma
Interventions
Procedure: conventional lymph node dissection
Procedure: unconventional lymph node dissection
First Posted Date
2015-08-18
Last Posted Date
2016-04-01
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
100
Registration Number
NCT02526771
Locations
🇨🇳

Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients

Not Applicable
Conditions
Recurrence
Hepatocellular Carcinoma
Interventions
Procedure: Hepatectomy
First Posted Date
2015-08-14
Last Posted Date
2016-10-21
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
160
Registration Number
NCT02523053
Locations
🇨🇳

Eastern hepatobilliary surgery hospital, Shanghai, Shanghai, China

Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy

Not Applicable
Conditions
Liver Neoplasms
Interventions
Other: Remote ischemia precondition
Other: None remote ischemia precondition
First Posted Date
2014-06-20
Last Posted Date
2014-06-20
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
100
Registration Number
NCT02168608
Locations
🇨🇳

Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China

Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma

Not Applicable
Conditions
Advanced Hepatocellular Carcinoma
Interventions
Procedure: TACE
Procedure: TACE+Sorafenib
First Posted Date
2014-05-29
Last Posted Date
2016-03-29
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
180
Registration Number
NCT02150317
Locations
🇨🇳

Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China

Preoperative Pain Control in Liver Surgery Patients

Not Applicable
Completed
Conditions
Pain, Postoperative
Hepatocellular Carcinoma
Interventions
Drug: Placebo (for Pregabalin)
First Posted Date
2013-08-16
Last Posted Date
2016-03-31
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
40
Registration Number
NCT01923948
Locations
🇨🇳

Eastern Hepatobiliary Surgery Hospital, Shanghai, China

Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients

Not Applicable
Conditions
Intrahepatic Cholangiocarcinoma
Interventions
Procedure: Resection
Radiation: Radiotherapy
First Posted Date
2013-08-02
Last Posted Date
2016-03-31
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
200
Registration Number
NCT01914289
Locations
🇨🇳

Eastern Hepatobiliary Surgery Hospital, Shanghai, Shanghai, China

Surgical Resection Versus Percutaneous Local Ablative Therapy for Hepatocellular Carcinoma

Not Applicable
Conditions
Hepatocellular Carcinoma With CSPH
Interventions
Procedure: SR
Procedure: PLAT
First Posted Date
2013-05-22
Last Posted Date
2016-03-31
Lead Sponsor
Eastern Hepatobiliary Surgery Hospital
Target Recruit Count
160
Registration Number
NCT01860222
Locations
🇨🇳

Eastern Hepatobiliary Surgery Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath